Absorption, excretion, and biotransformation of procainamide-C 14 in the dog and rhesus monkey
- PMID: 4998538
Absorption, excretion, and biotransformation of procainamide-C 14 in the dog and rhesus monkey
Similar articles
-
Metabolism of procainamide in rhesus monkey and man.Clin Pharmacol Ther. 1972 May-Jun;13(3):366-71. doi: 10.1002/cpt1972133366. Clin Pharmacol Ther. 1972. PMID: 4623713 No abstract available.
-
Pharmacokinetics of procainamide.Arch Intern Med. 1972 Sep;130(3):366-9. Arch Intern Med. 1972. PMID: 5055693 No abstract available.
-
Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.J Pharmacol Exp Ther. 1971 Feb;176(2):302-11. J Pharmacol Exp Ther. 1971. PMID: 4998689 No abstract available.
-
Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.J Pharmacol Exp Ther. 1973 Aug;186(2):323-30. J Pharmacol Exp Ther. 1973. PMID: 4719785 No abstract available.
-
[Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].Przegl Lek. 1984;41(5):379-83. Przegl Lek. 1984. PMID: 6206523 Review. Polish. No abstract available.
Cited by
-
Pharmacokinetics in man of the N-acetylated metabolite of procainamide.J Pharmacokinet Biopharm. 1975 Aug;3(4):223-35. doi: 10.1007/BF01066919. J Pharmacokinet Biopharm. 1975. PMID: 1185521 No abstract available.
-
Clinical pharmacokinetics of N-acetylprocainamide.Clin Pharmacokinet. 1982 May-Jun;7(3):206-20. doi: 10.2165/00003088-198207030-00002. Clin Pharmacokinet. 1982. PMID: 6178545 Review.
-
Significance of the acetylation phenotype and the therapeutic effect of procainamide.Eur J Clin Pharmacol. 1979 Feb 19;15(1):63-8. doi: 10.1007/BF00563559. Eur J Clin Pharmacol. 1979. PMID: 84761 Clinical Trial.